Lumexa Imaging provides outpatient diagnostic imaging services, including MRI and CT scans, through centers in the United States. LMRI reports earnings on Tue, Nov 10, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). In the past 30 days there were 1 dark pool print.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 5 | Truist Securities | Initiated | Buy | |
| Sep 25 | Keybanc | Initiated | Buy | |
| Aug 28 | Barclays | Target raised | Buy | |
| May 20 | Barclays | Maintained | Buy |
Whale Options Flow
90DNo whale options trades in LMRI in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LMRI is in one of them and how their past LMRI trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered LMRI in an article yet. Here's the latest on the wider market.
About Lumexa Imaging Holdings
Lumexa Imaging is a provider of outpatient diagnostic imaging services based in Raleigh, North Carolina. It operates imaging centers in metropolitan areas across several states in the United States, offering scans such as MRI and CT. Its customers include patients, referring physicians, health systems and payors, and it also works with health systems through joint ventures.
- Headquarters
- Raleigh, NC